Using holographic screens instead of monitors during gastrointestinal endoscopies
Mixed-reality Holographic Screens as the Replacement of Monitors in the Endoscopy Suite: a Multicenter Study
This study is testing if using holographic screens during gastrointestinal procedures can help doctors perform better and improve patient outcomes.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 10 (estimated) |
| Ages | 18 Years to 89 Years |
| Sex | All |
| Sponsor | Instituto Ecuatoriano de Enfermedades Digestivas Academic / other |
| Locations | 1 site (Guayaquil, Guayas) |
| Trial ID | NCT05640401 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of mixed reality technology, specifically using holographic screens, during gastrointestinal endoscopic procedures. It aims to enhance situational awareness and provide 3D spatial guidance for expert endoscopists. By utilizing HoloLens2TM and HXtend™ software, the research seeks to determine if mixed reality can improve the efficiency and outcomes of procedures like colonoscopy and ERCP. The trial is multicenter, involving collaboration between various institutions in Ecuador.
Who should consider this trial
Good fit: Ideal candidates for this study are expert gastrointestinal endoscopists performing diagnostic procedures such as colonoscopy, cholangioscopy, ERCP, or EUS.
Not a fit: Patients who refuse to participate or have inadequate internet connectivity will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the precision and safety of gastrointestinal endoscopic procedures.
How similar studies have performed: While augmented and virtual reality have shown success in various medical fields, the application of mixed reality in gastroenterology is relatively novel and untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Expert gastrointestinal endoscopists performing diagnostic colonoscopy, cholangioscopy, ERCP or EUS evaluation/intervention * Written informed consent provided Exclusion Criteria: * Refuse to participate in the study or to sign corresponding informed consent * Internet connection less than 100 MBs per second.
Where this trial is running
Guayaquil, Guayas
- Instituto Ecuatoriano de Enfermedades Digestivas (IECED) — Guayaquil, Guayas, Ecuador (Recruiting)
Study contacts
- Principal investigator: Carlos Robles-Medranda, MD FASGE — Instituto Ecuatoriano de Enfermedades Digestivas (IECED)
- Study coordinator: Carlos Robles-Medranda, MD FASGE
- Email: carlosoakm@yahoo.es
- Phone: +59342109180
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.